Chemist David Liu explains how gene editing is paving the way to treating and even curing certain genetic diseases.
Academic rigor, journalistic flair
Articles on Genetic diseases
Displaying all articles
At the Third International Summit on Human Genome Editing, experts gather to discuss the path forward for CRISPR and other gene-editing technologies
FTD leads to changes in personality and behavior. Understanding its genetic and molecular causes could lead to new ways to treat neurodegenerative diseases.
Gene therapies and vaccines are often injected into muscle cells that are inefficient at producing desired proteins. Making them work more like liver cells could lead to better treatment outcomes.
Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.
The first full human genome was sequenced 20 years ago. Now, a project is underway to sequence 1 million genomes to better understand the complex relationship between genetics, diversity and disease.
Using ‘base editing’, researchers have cured progeria in mice. This genetic syndrome causes premature ageing in humans – those with the disease usually don’t live past the age of 13.
Recent studies using CRISPR to fast-track genetic studies into human disease genes appear flawed.
Should Australia allow the creation of babies with DNA from more than two people? This reproductive technology could prevent babies being born with mitochondrial disease, so the simple answer is yes.
Despite the fact that rare diseases aren’t actually so rare, it appears they suffer from a branding problem in Canada.
Cystic fibrosis, spinal muscular atrophy and fragile X syndrome are serious diseases, and most couples carrying the genetic mutations for these don’t know it. Should they all be tested?
Canadian insurance companies argue that a new law denying them access to genetic test results will raise the cost of insurance for everyone. That’s doubtful.
A new report from the National Academies of Science and Medicine outlines conditions that have to be met before gene editing that results in heritable genomic changes can be considered.
Experts from around the world are in the US to discuss the scientific, ethical and governance issues linked to human gene editing. Here are five reasons they shouldn’t ban research in the field.
Today is the start of World Retinal Week. Establishing retinal degenerative disorders in Africa is challenged by the unique genetic diversity of Africans.
Scientists have discovered that a single gene may reveal a weakness in the development of schizophrenia that could help doctors prevent the condition.
That genetic editing techniques have become as straightforward as they have poses questions for how we want them to be used.
Leading researchers have called for a ban on using a precise gene-editing technology on humans. How can CRISPR advance science and why is it raising concerns?
There’s a huge variety in physical appearance in Latin America: there are indigenous native Americans, descendants of African slaves, Europeans and Middle Easterners of all kinds, and Chinese and Japanese…
The UK government has announced its intention to draft proposals allowing carriers of mitochondrial disease to have babies using a controversial IVF treatment that’s currently prohibited. The procedure…
Top contributors
-
Professor and Director, Centre for Genetic Diseases, Monash Institute of Medical Research, Monash University
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Merlin Crossley is a Friend of The Conversation.
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Professor of Bioethics, University of Sydney
-
Professor of Social Anthropology, University of Manchester
-
Professor of Molecular Genetics and Microbiology, University of Florida
-
Professor of Chemistry, Connecticut College
-
Professor of Ethics, Keele University
-
Professor of neuroscience, Cardiff University
-
Medical Biological Scientist: Scientific Officer and Project Leader of the Retinal Degenerative Disorders research group, Division of Human Genetics, UCT, University of Cape Town
-
Research Fellow, The University of Western Australia
-
Phd Student in Population Genetics, The University of Western Australia
-
Postdoctoral Associate in Science and Society, Duke University
-
Professor, The University of Western Australia
-
Professor of Economics, University of Guelph
